HRP970362A2 - Method for treating and preventing neurodegenerative disorders - Google Patents

Method for treating and preventing neurodegenerative disorders

Info

Publication number
HRP970362A2
HRP970362A2 HR60/021,571A HRP970362A HRP970362A2 HR P970362 A2 HRP970362 A2 HR P970362A2 HR P970362 A HRP970362 A HR P970362A HR P970362 A2 HRP970362 A2 HR P970362A2
Authority
HR
Croatia
Prior art keywords
pct
treating
neurodegenerative disorders
preventing neurodegenerative
sec
Prior art date
Application number
HR60/021,571A
Other languages
English (en)
Inventor
Richard Thomas Carroll
Richard Dennis Dyer
Lillian Jane Robichaud
Brenda De Rae Shivers
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HRP970362A2 publication Critical patent/HRP970362A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
HR60/021,571A 1996-07-11 1997-07-03 Method for treating and preventing neurodegenerative disorders HRP970362A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2157196P 1996-07-11 1996-07-11

Publications (1)

Publication Number Publication Date
HRP970362A2 true HRP970362A2 (en) 1998-04-30

Family

ID=21804973

Family Applications (1)

Application Number Title Priority Date Filing Date
HR60/021,571A HRP970362A2 (en) 1996-07-11 1997-07-03 Method for treating and preventing neurodegenerative disorders

Country Status (22)

Country Link
US (1) US5912259A (de)
EP (1) EP0914122B1 (de)
JP (1) JP2001508028A (de)
KR (1) KR20000023683A (de)
CN (1) CN1145481C (de)
AT (1) ATE250416T1 (de)
AU (1) AU726664B2 (de)
BR (1) BR9710467A (de)
CA (1) CA2255073A1 (de)
CO (1) CO4940509A1 (de)
DE (1) DE69725147T2 (de)
DK (1) DK0914122T3 (de)
ES (1) ES2205247T3 (de)
HR (1) HRP970362A2 (de)
IL (1) IL127487A (de)
NO (1) NO990076D0 (de)
NZ (1) NZ332763A (de)
PL (1) PL331049A1 (de)
PT (1) PT914122E (de)
TR (1) TR199900040T2 (de)
WO (1) WO1998002160A1 (de)
ZA (1) ZA976142B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003104423A2 (en) * 2002-06-11 2003-12-18 Roy Ogle Meningeal-derived stem cells
WO2009137109A1 (en) * 2008-05-08 2009-11-12 Rutgers, The State University Endorphin therapy compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83152B (pt) * 1985-08-09 1989-03-30 Lilly Co Eli Processo para a preparacao de compostos di-t-butilfenoicos
DE69027472T2 (de) * 1989-04-07 1996-12-05 Lilly Co Eli Arylsubstituierte Rhodaninderivate
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
US5192753A (en) * 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
EP0722729A3 (de) * 1995-01-23 1997-11-26 Eli Lilly And Company Aryl-substituierte Rhodaninen zur Behandlung multipler Sklerose
ATE301457T1 (de) * 1995-06-12 2005-08-15 Searle & Co Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor

Also Published As

Publication number Publication date
ATE250416T1 (de) 2003-10-15
DE69725147D1 (de) 2003-10-30
ZA976142B (en) 1998-02-02
KR20000023683A (ko) 2000-04-25
AU3649197A (en) 1998-02-09
HK1020533A1 (en) 2000-05-12
IL127487A0 (en) 1999-10-28
NZ332763A (en) 2000-07-28
PT914122E (pt) 2003-12-31
NO990076L (no) 1999-01-08
DK0914122T3 (da) 2003-12-22
CN1223582A (zh) 1999-07-21
JP2001508028A (ja) 2001-06-19
CO4940509A1 (es) 2000-07-24
PL331049A1 (en) 1999-06-21
EP0914122A1 (de) 1999-05-12
WO1998002160A1 (en) 1998-01-22
CA2255073A1 (en) 1998-01-22
CN1145481C (zh) 2004-04-14
BR9710467A (pt) 1999-08-17
US5912259A (en) 1999-06-15
TR199900040T2 (xx) 1999-04-21
IL127487A (en) 2002-04-21
DE69725147T2 (de) 2004-07-22
EP0914122B1 (de) 2003-09-24
AU726664B2 (en) 2000-11-16
NO990076D0 (no) 1999-01-08
ES2205247T3 (es) 2004-05-01

Similar Documents

Publication Publication Date Title
AU616127B2 (en) A method of treating anxiety related disorders using sertraline
EP0604433A4 (de) Zusammensetzung und methode zur behandlung von krankheiten.
BG103646A (en) Arylsulphonamides, their analogues and application for the treatment of neurodegenerative diseases
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
IL125544A0 (en) Novel substituted cyclic amino acids as pharmaceutical agents
ZA972199B (en) Novel bridged cyclic amino acids as pharmaceutical agents.
IL128416A0 (en) Pharmaceutical composition for the treatment of alzheimer's disease
WO1999045011A8 (en) Glycine transport inhibitors
HRP970560B1 (en) Substituted gamma aminobutyric acids as pharmaceutical agents
ZA9711279B (en) Method for treating and preventing neurological disorders and promoting wound healing.
BG104685A (en) Glycine transport inhibitors
DE59410052D1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
AU2003296341A8 (en) System and method for treating Parkinson's Disease and other movement disorders
GEP20032914B (en) Derivatives of 1,3,4-Oxadiazolone
WO1994025012A3 (en) Medicaments for treatment of migraine, epilepsy and feeding disorders
ZA962715B (en) Pharmaceutical agents for the treatment of Alzheimer's disease.
ZA976142B (en) Method for treating and preventing neurodegenerative disorders.
EP0744176A3 (de) Arzneimittel zur Hemmung von Knochenschwund
TW285640B (de)
ZA964198B (en) Treatment regime for skin.
AU1496597A (en) 1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's Disease
EP1447090B8 (de) Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen
CA2158173A1 (en) Method of treating addictive behaviors
EP0768083A3 (de) Die Verwendung von Sertralin zur Behandlung Post-Myocard-Infarkt-Patienten
AU1209501A (en) Method for treating parkinson's disease by administering (-)-5-keto-2-n,n-di-n-propylamino-tetrahydrotetralin

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040705

Year of fee payment: 8

ODBI Application refused